Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

CSIR-CDRI signs agreement with Marc Labs to develop drug for heart attack and stroke

The agreement has been signed for the development of a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen induced platelet aggregation. This may be helpful in treating patient population of coronary and cerebral artery diseases

Engineering | 12/06/2021 | By Darshana

Pharma Industrial Magazine

All magazines | Subscribe

Interviews

QuEST's AI solution will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms

Krish Kupathil, Global Head, Hi-Tech and Digital, QuEST Global

We had recently developed a robust AI-powered solution that will enable healthcare professionals to accelerate the screening of COVID-19 patients with pneumonia symptoms.Using advanced deep learning models, this AI-...

We continue to be committed to our clients? business while putting the safety of patients: Paraxel

Jamie Macdonald, Chief Executive Officer, Parexel

Parexel is focused on supporting the development of innovative new therapies to improve patient health. They do this through a suite of services that help life science and biopharmaceutical customers across the glob...

A Special Interaction With Mylab That Discovered First Made In India COVID-19 Testing Kit

Gautam Wankhede, Director Medical Affairs, Mylab Discovery Solutions

According to the Pune-based molecular diagnostics startup Mylab, the kit named as Mylab PathoDetect COVID-19 Qualitative PCR kit, is the first one to receive commercial approval from the national regulatory body.

All interviews